Commercial
Advanced Search
MPDocType
  
Title
  
MPPolicyNumber
  
MPNotificationIssuedDate
  
MPEffectiveDate
  
MPReissuedDate
  
MPArchiveNotifEffDate
  
MPSALogCreatedOn
  
MPPolicyChangeTypeslt
  
MPRevisionDate
  
MPSiteActivityRemovedDate
  
NotificationsMultiple Surgery Payment Reduction11.00.10z6/1/2026 10:00 AM9/1/20266/1/2026Coverage and/or Reimbursement Position
NotificationsTildrakizumab-asmn (Ilumya®)08.01.48c6/12/2026 1:00 PM9/14/20266/12/2026Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
New PoliciesSite of Care for Elective Procedures [Hospital Outpatient Setting to Ambulatory Surgical Center (ASC)]12.06.003/2/2026 3:00 PM6/1/20266/1/2026This is a New Policy.6/1/2026
New PoliciesLevel of Care for Elective Procedures (Hospital Inpatient to Hospital Outpatient Level of Care)12.06.013/2/2026 12:00 PM6/1/20266/1/2026This is a New Policy.
Updated PoliciesNebulizers and Inhalation Solutions05.00.15u2/1/20266/1/2026Medical Necessity Criteria
Updated PoliciesHospital Readmissions00.01.47e6/1/20266/1/2026Coverage and/or Reimbursement Position
Updated PoliciesMusculoskeletal Services (Independence)00.01.66s3/2/2026 11:00 AM6/1/20266/1/2026Medical Necessity Criteria
Updated PoliciesLurbinectedin (Zepzelca®)08.01.67d6/1/20266/1/2026Medical Necessity Criteria
Updated PoliciesPenpulimab-kcqx08.02.42a6/1/20266/1/2026Medical Necessity Criteria
Updated PoliciesDostarlimab-gxly (Jemperli)08.01.79g6/1/20266/1/2026Medical Necessity Criteria
Updated PoliciesCosibelimab-ipdl (Unloxcyt™)08.02.40a6/1/20266/1/2026Medical Necessity Criteria
Updated PoliciesZenocutuzumab-zbco (Bizengri®)08.02.38a6/1/20266/1/2026Medical Necessity Criteria
Updated PoliciesTislelizumab-jsgr (Tevimbra®)08.02.23a6/1/20266/1/2026Medical Necessity Criteria
Updated PoliciesPresumptive and Definitive Drug Testing in Substance Abuse and Pain Management Treatments06.02.44s3/6/2026 9:00 AM6/5/20266/5/2026Coverage and/or Reimbursement Position;Medical Necessity Criteria;Medical Coding;General Description, Guidelines, or Informational Update
Updated PoliciesApheresis Therapy06.03.04p3/10/2026 10:00 AM6/8/20266/8/2026Medical Necessity Criteria
Updated PoliciesHome Health Care Services02.01.01h6/8/20266/8/2026General Description, Guidelines, or Informational Update
Updated PoliciesWheelchair Options and Accessories05.00.67v6/8/20266/15/2026Medical Necessity Criteria6/15/2026
Updated PoliciesMirvetuximab soravtansine-gynx (Elahere®)08.02.01d6/15/20266/15/2026Medical Necessity Criteria
Updated PoliciesErythropoiesis-Stimulating Agents (ESAs)08.00.75r6/15/20266/15/2026Medical Necessity Criteria;Medical Coding
Updated PoliciesPemetrexed (Pemfexy™)08.00.87p6/15/20266/15/2026Medical Necessity Criteria;Medical Coding
Updated PoliciesMusculoskeletal Services (Independence)00.01.66t6/14/20266/15/2026Medical Necessity Criteria;General Description, Guidelines, or Informational Update
Updated PoliciesToripalimab-tpzi (Loqtorzi®)08.02.20b6/15/20266/15/2026Medical Necessity Criteria
Updated PoliciesTarlatamab-dlle (Imdelltra®) for intravenous use08.02.27a6/15/20266/15/2026Medical Necessity Criteria
Reissue PoliciesPercutaneous Image-Guided Lumbar Decompression (PILD) for Spinal Stenosis11.15.22e1/1/20266/10/20266/10/2026
Reissue PoliciesAutologous Chondrocyte Implantation (ACI) and Other Cell-based Treatments of Focal Articular Cartilage Lesions (Independence Administrators)11.14.06j1/10/20216/10/20266/10/2026
Reissue PoliciesSurgical Treatment of Femoroacetabular Impingement (Independence Administrators)11.14.23d1/10/20216/10/20266/10/2026
Reissue PoliciesEndovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions11.02.17j1/1/20266/10/20266/11/2026
Reissue PoliciesAmbulatory Electrocardiography (AECG) Monitoring and Mobile Cardiac Outpatient Telemetry (MCOT) Monitoring07.02.21r7/21/20256/10/20266/11/2026
Reissue PoliciesAllogeneic Processed Thymus Tissue-agdc (Rethymic®)08.01.88b11/17/20256/10/20266/11/2026
Reissue PoliciesProcedures for the Treatment of Gastroesophageal Reflux Disease (GERD)11.03.11r1/1/20266/10/20266/11/2026
Reissue PoliciesFecal Microbiota Transplantation (FMT)07.05.08d7/1/20236/10/20266/11/2026
Reissue PoliciesGastric Electrical Stimulation (Enterra™), Gastric Pacing11.03.15m10/1/20256/10/20266/11/2026
Reissue PoliciesAblation of Lung Tumors11.00.16k1/1/20266/10/20266/11/2026
Reissue PoliciesSerodiagnosis of Inflammatory Bowel Disease (IBD) and the Prometheus® IBD sgi Diagnostic™ Test06.02.17h4/1/20206/10/20266/11/2026
Reissue PoliciesInstrument-Based Vision Screening07.13.12d1/1/20166/10/20266/11/2026
Reissue PoliciesEndovascular Grafts for Abdominal Aortic Aneurysms (AAA), Aorto-Iliac Aneurysms, and Infrarenal Aortic Aneurysms11.02.10p1/1/20226/10/20266/11/2026
Reissue PoliciesDirect Endoscopic Necrosectomy (DEN) for the Treatment of Pancreatic Necrosis11.03.161/20/20256/10/20266/12/2026
Reissue PoliciesOsteochondral Allograft Transplantation (Independence Administrators)11.14.12f1/10/20216/10/20266/12/2026
Reissue PoliciesMeniscal Allograft Transplantation and Meniscal Implants (Independence Administrators)11.14.03h1/10/20216/10/20266/12/2026
Reissue PoliciesOsteochondral Autograft Transplantation (Independence Administrators)11.14.09h1/10/20216/10/20266/12/2026
Reissue PoliciesCatheter Ablation of Cardiac Arrhythmias11.02.06r1/1/20256/10/20266/12/2026
Coding UpdateModifier 25: Significant, Separately Identifiable Evaluation and Management Service by the Same Physician or Other Qualified Health Care Professional on the Same Day of the Procedure or Other Service03.00.06ae4/1/20266/15/2026
Connect with Us

2026 Independence Blue Cross

Independence Blue Cross is a subsidiary of Independence Health Group, Inc. — independent licensees of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.